References
- Tran DD, Groeneveld ABJ, Vander Meulen J, Nauta JJ, Strack van Schijndel RJ, Thijs LG, et al.Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med. 1990; 18(2):474-479. PubMed | Google Scholar
- Cholongitas E, Senzolo M, Patch D, Kwong K, Nikolopoulou V, Leandro G et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther. 2006;23(7):883–893. PubMed | Google Scholar
- O’Brien AJ, Welch CA, Singer M, Harrison DA. Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients. Intensive Care Med. 2012; 38(6):991-1000. PubMed | Google Scholar
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med.1999; 340(6):448-54. PubMed | Google Scholar
- Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982; 389:39-48. PubMed | Google Scholar
- Gabay C, Smith MF, Eidlen D, Arend WP. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest. 1997; 99(12):2930-40. PubMed | Google Scholar
- Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003; 101(7):2461-3. PubMed | Google Scholar
- Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis. 2000; 148(2):209-14. PubMed | Google Scholar
- De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC.Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996; 83(3): 349-353. PubMed | Google Scholar
- Ikei S, Ogawa M, Yamaguchi Y. Blood concentrations of polymorphonuclear leukocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis. J Gastroenterol Hepatol.1998; 13(12):1274-1283. PubMed | Google Scholar
- Pinilla JC, Hayes P, Laverty W, Arnold C, Laxdal V. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunctions. Surgery. 1998; 124(4): 799-805. PubMed | Google Scholar
- Rau B, Steinbach G, Baumgart K, Gansauge F, Grunert A, Beger HG et al. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med. 2000; 28(3):736-742. PubMed | Google Scholar
- Waydhas C, Nast-Kolb D, Trupka A, Zettl R, Kick M, Wiesholler J, et al. Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma. 1996; 40(4):624-630. PubMed | Google Scholar
- Lobo SM , Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Mélot C, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003; 123(6):2043-9. PubMed | Google Scholar
- Vincent JL, Donadello K, Schmit X. Biomarkers in the critically ill patient: C-reactive protein. Crit Care Clin.2011; 27(2):241-51. PubMed | Google Scholar
- Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. WJ ACCP-SCCM Consensus Conference: Definition of sepsis and multiple organe failure and guidelines for the use innovative therapies in sepsis. Chest. 1992; 101(6): 1644-55. PubMed | Google Scholar
- Vincent JL. Le manuel de réanimation, soins intensifs et médicine d’urgence. Troisième édition. 2009. France. Springer-Verlag. PubMed | Google Scholar
- Presterl E, Staudinger T, Pettermann M, Burgmann H, Winkler S, Frass M, et al.Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med. 1997; 156 (3 Pt 1): 825-832. PubMed | Google Scholar
- Maury CP. Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases. J Clin Pathol. 1989; 42(10):1078-1082. PubMed | Google Scholar
- Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragão A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998; 24(10):1052-1056. PubMed | Google Scholar
- Schentag JJ, O’Keeffe D, Marmion M, Wels PB. C-reactive protein as an indicator of infection relapse in patients with abdominal sepsis. Arch Surg. 1984;119(3):300-304. PubMed | Google Scholar
- Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein: a clinical marker in community-acquired pneumonia. Chest. 1995;108(5):1288-1291. PubMed | Google Scholar
- Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med. 1995;21(7): 602-605. PubMed | Google Scholar
- Volanakis JE. Human C-reactive protein: expression, structure, and function. MolImmunol. 2001; 38(2-3):189-97. PubMed | Google Scholar
- Assicot M, Gendrel D, Carsin H, Raymond J, Guinaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993; 341 (8844):515-518. PubMed | Google Scholar
- Meisner M, Heide A, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit care. 2006;10(1):R1. PubMed | Google Scholar
- Christ-Crain M, Stolz D, Binginser R, Miedinger D, Huber PR, ZimmerliW, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J RespirCrit Care Med. 2006;174(1):84-93. PubMed | Google Scholar
- Nijsten M, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, et al.Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med. 2000; 28(2):458-461. PubMed | Google Scholar
- Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The Pro HOSP randomized controlled trial. JAMA. 2009; 302(10):1059-66. PubMed | Google Scholar
- Bauer S, Lamy O. Utilité du dosage de la CRP dans le diagnostic, le pronostic et le suivi de la pneumonie acquise dans la communauté. Rev Med Suisse. 2010; 6(269):2068-2073. PubMed | Google Scholar
- Lemarié J, Gibot S. Combinaison de biomarqueurs pour le diagnostic du sepsis en réanimation. Réanimation. 2013 ; 22(3) :306-313. PubMed | Google Scholar
- Cook NR, Paynter NP. Performance of reclassification statistics in comparing risk prediction models.Biom J. 2011; 53(2):237–58. PubMed | Google Scholar